References
- Rail T W. Central nervous system stimulants. The xanthines. The Pharmacological Basis of Therapeutics, Goodman, A Gilman, L S Goodman, A Gilman. Macmillan, New York 1980; 592–607
- Svedmyr R, Simonsson B G. Drugs in the treatment of asthma. Respiratory Pharmacology, J G Widdicombe. Pergamon Press, Oxford 1981; 657–701
- Upton R A., Thiercelin J F., Moore J K., Riegelman S. A method for estimating within-individual variability in clearance and in volume of distribution from standard bioavailability studies. J Pharmacokin Biopharm 1982; 10: 135, 146
- Snedecor G W., Cochran W G. Statistical Methods. State University Press, Ames, IA 1967
- Christensen H D., Witsett L T. Measurements of xanthines and their metabolites by means of high pressure liquid chromatography. Chromat Science Serie 1979; 20: 507, 535
- Gibaldi M, Perrier D. Pharmacokinetics. Marcel Dek-ker, New York 1982
- Spiteri M A., Millar A B., Pavia D, Clarke S W. Subcutaneous adrenaline versus terbutaline in the treatment of acute severe asthma. Thorax 1988; 43: 19, 23
- Ellul-Micalef R. The acute effect of corticosteroids in bronchial asthma. Eur J Resp Dis 1982; 63: 118–125, (Suppl. 122)
- Hendeles L, Weinberger M. Theophylline. A “state of the art” review. Pharmacotherapy 1983; 3: 2, 44
- Waxier S H., Schack J A. Administration of aminophylline. JAMA 1950; 143: 736, 739
- Goldfarb G, Simon R. Provocation of sulfite sensitive asthma. J Allergy Clin Immunol 1984; 73: 135